Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of ZNF514 mRNA | CTD | PMID:37199045 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ZNF514 mRNA | CTD | PMID:32763439 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of ZNF514 mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of ZNF514 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of ZNF514 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ZNF514 promoter | CTD | PMID:27901495 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ZNF514 gene | CTD | PMID:31601247 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of ZNF514 mRNA | CTD | PMID:26079696 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ZNF514 mRNA | CTD | PMID:27594783 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ZNF514 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ZNF514 mRNA | CTD | PMID:20106945 and PMID:25562108 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of ZNF514 mRNA | CTD | PMID:23649840 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of ZNF514 mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of ZNF514 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ZNF514 mRNA | CTD | PMID:28001369 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of ZNF514 mRNA | CTD | PMID:25583101 | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of ZNF514 mRNA | CTD | PMID:26079696 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of ZNF514 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF514 mRNA | CTD | PMID:27188386 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of ZNF514 mRNA | CTD | PMID:24935251 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ZNF514 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ZNF514 mRNA | CTD | PMID:24935251 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF514 mRNA | CTD | PMID:26272509 and PMID:28001369 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF514 mRNA | CTD | PMID:27188386 | |